A	a	O	O	O	O
novel	novel	O	O	O	O
animal	animal	O	O	O	O
model	model	O	O	O	O
to	to	O	O	O	O
evaluate	evaluate	O	O	O	O
the	the	O	O	O	O
ability	ability	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
drug	drug	O	O	O	O
delivery	delivery	O	O	O	O
system	system	O	O	O	O
to	to	O	O	O	O
promote	promote	O	O	O	O
the	the	O	O	O	O
passage	passage	O	O	O	O
through	through	O	O	O	O
the	the	O	O	O	O
BBB.The	bbb.the	O	O	O	O
purpose	purpose	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
investigation	investigation	O	O	O	O
was	was	O	O	O	O
to	to	O	O	O	O
explore	explore	O	O	O	O
the	the	O	O	O	O
potentiality	potentiality	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
novel	novel	O	O	O	O
animal	animal	O	O	O	O
model	model	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
used	used	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
in	in	O	O	O	O
vivo	vivo	O	O	O	O
evaluation	evaluation	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
ability	ability	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
drug	drug	O	O	O	O
delivery	delivery	O	O	O	O
system	system	O	O	O	O
to	to	O	O	O	O
promote	promote	O	O	O	O
the	the	O	O	O	O
passage	passage	O	O	O	O
through	through	O	O	O	O
the	the	O	O	O	O
blood-brain	blood-brain	O	O	O	O
barrier	barrier	O	O	O	O
(	(	O	O	O	O
BBB	bbb	O	O	O	O
)	)	O	O	O	O
and/or	and/or	O	O	O	O
to	to	O	O	O	O
improve	improve	O	O	O	O
the	the	O	O	O	O
brain	brain	O	O	O	O
localization	localization	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
bioactive	bioactive	O	O	O	O
compound	compound	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
Tween	tween	O	O	O	O
80-coated	80-coated	O	O	O	O
poly-L-lactid	poly-l-lactid	O	O	O	O
acid	acid	O	O	O	O
nanoparticles	nanoparticles	O	O	O	O
was	was	O	O	O	O
used	used	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
model	model	O	O	O	O
of	of	O	O	O	O
colloidal	colloidal	O	O	O	O
drug	drug	O	O	O	O
delivery	delivery	O	O	O	O
system	system	O	O	O	O
,	,	O	O	O	O
able	able	O	O	O	O
to	to	O	O	O	O
trespass	trespass	O	O	O	O
the	the	O	O	O	O
BBB	bbb	O	O	O	O
.	.	O	O	O	O

Tacrine	tacrine	O	O	OTHERS	I
,	,	O	O	O	O
administered	administered	O	O	O	O
in	in	O	O	O	O
LiCl	licl	CHEMICALS	O	OTHERS	I
pre-treated	pre-treated	O	O	O	O
rats	rats	O	O	O	O
,	,	O	O	O	O
induces	induces	O	O	O	O
electrocorticographic	electrocorticographic	O	O	O	O
seizures	seizures	O	DISEASE	OTHERS	I
and	and	O	O	O	O
delayed	delayed	O	O	O	O
hippocampal	hippocampal	O	O	OTHERS	I
damage	damage	O	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
toxic	toxic	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
tacrine-loaded	tacrine-loaded	O	O	O	O
poly-L-lactid	poly-l-lactid	O	O	O	O
acid	acid	O	O	O	O
nanoparticles	nanoparticles	O	O	O	O
(	(	O	O	O	O
5mg/kg	5mg/kg	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
a	a	O	O	O	O
saline	saline	CHEMICALS	O	OTHERS	I
solution	solution	CHEMICALS	O	OTHERS	I
of	of	O	O	O	O
tacrine	tacrine	O	O	OTHERS	I
(	(	O	O	O	O
5mg/kg	5mg/kg	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
an	an	O	O	O	O
empty	empty	O	O	O	O
colloidal	colloidal	O	O	O	O
nanoparticle	nanoparticle	O	O	O	O
suspension	suspension	O	O	O	O
were	were	O	O	O	O
compared	compared	O	O	O	O
following	following	O	O	O	O
i.p	i.p	O	O	O	O
.	.	O	O	O	O

administration	administration	O	O	O	O
in	in	O	O	O	O
LiCl-pre-treated	licl-pre-treated	O	O	O	O
Wistar	wistar	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

All	all	O	O	O	O
the	the	O	O	O	O
animals	animals	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
tacrine-loaded	tacrine-loaded	O	O	O	O
nanoparticles	nanoparticles	O	O	O	O
showed	showed	O	O	O	O
an	an	O	O	O	O
earlier	earlier	O	O	O	O
outcome	outcome	O	O	O	O
of	of	O	O	O	O
CNS	cns	O	O	O	O
adverse	adverse	O	O	O	O
symptoms	symptoms	O	O	O	O
,	,	O	O	O	O
i.e.	i.e.	O	O	O	O
epileptic	epileptic	O	DISEASE	OTHERS	I
onset	onset	O	O	O	O
,	,	O	O	O	O
with	with	O	O	O	O
respect	respect	O	O	O	O
to	to	O	O	O	O
those	those	O	O	O	O
animals	animals	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
free	free	O	O	O	O
compound	compound	O	O	O	O
(	(	O	O	O	O
10	10	O	O	O	O
min	min	O	O	O	O
vs.	vs.	O	O	O	O
22	22	O	O	O	O
min	min	O	O	O	O
respectively	respectively	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
addition	addition	O	O	O	O
,	,	O	O	O	O
tacrine-loaded	tacrine-loaded	O	O	O	O
nanoparticles	nanoparticles	O	O	O	O
administration	administration	O	O	O	O
induced	induced	O	O	O	O
damage	damage	O	O	OTHERS	I
of	of	O	O	OTHERS	I
neuronal	neuronal	O	O	OTHERS	I
cells	cells	O	O	OTHERS	I
in	in	O	O	O	O
CA1	ca1	O	O	O	O
field	field	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
hippocampus	hippocampus	O	O	O	O
in	in	O	O	O	O
all	all	O	O	O	O
treated	treated	O	O	O	O
animals	animals	O	O	O	O
,	,	O	O	O	O
while	while	O	O	O	O
the	the	O	O	O	O
saline	saline	CHEMICALS	O	OTHERS	I
solution	solution	CHEMICALS	O	OTHERS	I
of	of	O	O	O	O
tacrine	tacrine	O	O	OTHERS	I
only	only	O	O	O	O
in	in	O	O	O	O
60	60	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
animals	animals	O	O	O	O
.	.	O	O	O	O

Empty	empty	O	O	O	O
nanoparticles	nanoparticles	O	O	O	O
provided	provided	O	O	O	O
similar	similar	O	O	O	O
results	results	O	O	O	O
to	to	O	O	O	O
control	control	O	O	O	O
(	(	O	O	O	O
saline-treated	saline-treated	O	O	O	O
)	)	O	O	O	O
group	group	O	O	O	O
of	of	O	O	O	O
animals	animals	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
conclusion	conclusion	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
evaluation	evaluation	O	O	O	O
of	of	O	O	O	O
time-to-onset	time-to-onset	O	O	O	O
of	of	O	O	O	O
symptoms	symptoms	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
severity	severity	O	O	O	O
of	of	O	O	O	O
neurodegenerative	neurodegenerative	O	O	O	O
processes	processes	O	O	O	O
induced	induced	O	O	O	O
by	by	O	O	O	O
the	the	O	O	O	O
tacrine-lithium	tacrine-lithium	O	O	O	O
model	model	O	O	O	O
of	of	O	O	O	O
epilepsy	epilepsy	O	DISEASE	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
rat	rat	O	O	O	O
,	,	O	O	O	O
could	could	O	O	O	O
be	be	O	O	O	O
used	used	O	O	O	O
to	to	O	O	O	O
evaluate	evaluate	O	O	O	O
preliminarily	preliminarily	O	O	O	O
the	the	O	O	O	O
capability	capability	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
drug	drug	O	O	O	O
delivery	delivery	O	O	O	O
system	system	O	O	O	O
to	to	O	O	O	O
trespass	trespass	O	O	O	O
(	(	O	O	O	O
or	or	O	O	O	O
not	not	O	O	O	O
)	)	O	O	O	O
the	the	O	O	O	O
BBB	bbb	O	O	O	O
in	in	O	O	O	O
vivo	vivo	O	O	O	O
.	.	O	O	O	O

